bioMérieux S.A.
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 4.0B 3.7B 3.6B 3.4B
Cost of revenue 1.8B 1.6B 1.6B 1.4B
Gross profit 2.2B 2.1B 2.0B 2.0B
Operating expense
Research & development 491.5M 460.1M 446.6M 385.8M
Selling general and admin 1.1B 1.0B 954.7M 815.6M
Other operating expenses -29.5M -24.6M -30.4M -26.2M
Operating income 637.9M 568.9M 625.7M 844M
Non operating interest income
Income 500K 1.1M 1.2M 1.7M
Expense 16M 15.8M 4.1M 9.1M
Other income expense
Pretax income 579.3M 437.5M 580.5M 774.5M
Tax provision 154.3M 114.5M 140.1M 175.6M
Net income 425.1M 322.8M 440.5M 598.2M
Basic EPS 3.7 3.0 3.8 5.1
Diluted EPS 3.6 3.0 3.8 5.1
Basic average shares 117.8M 118.2M 117.9M 118.3M
Diluted average shares 117.8M 118.2M 117.9M 118.3M
EBITDA 943.1M 841.8M 875.6M 1.1B
Net income from continuing op. 425.1M 322.8M 440.5M 598.2M
Minority interests 7.1M 34.8M 11.8M 2.9M
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 10 hours 20 minutes

21:39
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).